Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01836-7
Abstract: Patients with primary or secondary antiphospholipid syndrome (APS) have an increased risk of recurrent venous, arterial thrombosis and pregnancy complications. Therefore, determining thrombotic risk is important when individualizing antithrombotic therapy in patients with APS. To… read more here.
Keywords: aps patients; antiphospholipid syndrome; risk; risk factors ... See more keywords
Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with HELLP syndrome?
Sign Up to like & getrecommendations! Published in 2021 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2021.03.039
Abstract: BACKGROUND The characteristics of antiphospholipid syndrome (APS)-associated HELLP syndrome are poorly described, likely due to the low frequency of this combination of syndromes. OBJECTIVE To compare the characteristics and prognosis of HELLP syndrome in patients… read more here.
Keywords: hellp syndrome; aps patients; hellp aps; poor prognostic ... See more keywords
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome: a new tool for diagnosis of "seronegative" patients.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac045
Abstract: OBJECTIVES Antiphospholipid syndrome (APS) is a prothrombotic condition defined by recurrent thrombosis, pregnancy complications and circulating antiphospholipid antibodies (aPL), including anti-β2-Glycoprotein I (β2-GPI). In clinical practice it is possible to find patients with APS persistently… read more here.
Keywords: anti carb; antiphospholipid syndrome; carb; aps patients ... See more keywords
Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.14490
Abstract: The aim of this study is to evaluate development of side effects, thrombotic or obstetric complications in our antiphospholipid syndrome (APS) patient group, after vaccination against coronavirus disease 2019 (COVID‐19). A cohort was formed from… read more here.
Keywords: vaccination; side effects; antiphospholipid syndrome; cohort ... See more keywords
OP0356 Plasmablast proliferation is associated with toll like receptor 7 polymorphisms and upregulation of type i interferon, contributing to the antibody production in antiphospholipid syndrome
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.2816
Abstract: Background Antiphospholipid antibodies (aPL) as pathogenic autoantibodies in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are supported by a number of clinical, ex vivo and animal studies. Nevertheless, aPL are not eliminated by corticosteroid… read more here.
Keywords: toll like; antiphospholipid syndrome; aps patients; production ... See more keywords
FRI0184 SAFETY AND EFFICACY OF SPLENECTOMY IN THE TREATMENT OF ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED CYTOPENIAS
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.7610
Abstract: Background: Thrombocytopenia and autoimmune hemolytic anemia (AIHA) are common hematologic manifestations in primary antiphospholipid syndrome (APS). Although splenectomy is considered a second-line treatment in both primary immune thrombocytopenia (ITP) and idiopathic AIHA, its role in… read more here.
Keywords: antiphospholipid syndrome; none declared; treatment; splenectomy ... See more keywords
POS0775 APLS-ASSOCIATED RETINAL VASCULOPATHY AS A PRESENTATION OF THROMBOTIC MICROANGIOPATHY
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.3441
Abstract: Persistent antiphospholipid antibodies (aPL) positivity was a recognized risk factor for thrombotic events, obstetric morbidity and a variety of manifestations beyond thrombosis. The presence of some non-criteria manifestations including thrombocytopenia, hemolytic anemia, and APS nephropathy… read more here.
Keywords: associated retinal; thrombotic microangiopathy; retinal vasculopathy; aps patients ... See more keywords
Belimumab in primary antiphospholipid syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Lupus"
DOI: 10.1177/0961203316682102
Abstract: Sir, Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis and/ or pregnancy morbidity with persistently positive antiphospholipid antibodies (aPL). Patients with aPL may also experience thrombocytopenia, cardiac valve disease, nephropathy, skin ulcer, or… read more here.
Keywords: aps patients; antiphospholipid syndrome; disease; belimumab ... See more keywords
Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: additional information
Sign Up to like & getrecommendations! Published in 2020 at "Lupus"
DOI: 10.1177/0961203320911714
Abstract: Sir, I read with great interest the study by Sato et al. comparing factor Xa inhibitors for preventing recurrent thrombosis in heterogeneous patients with antiphospholipid syndrome (APS) with warfarin in the same group of patients… read more here.
Keywords: aps patients; information; factor inhibitors; study ... See more keywords
Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Lupus"
DOI: 10.1177/09612033211069762
Abstract: Background Retinal vasculopathy including retinal artery occlusion (RAO) or retinal vein occlusion (RVO) was recently found to occur more frequently in antiphospholipid syndrome (APS) patients than non-APS patients. This study aims to investigate the clinical… read more here.
Keywords: vasculopathy; antiphospholipid syndrome; risk factors; retinal vasculopathy ... See more keywords
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses
Sign Up to like & getrecommendations! Published in 2022 at "Lupus"
DOI: 10.1177/09612033221130975
Abstract: Objective The aim of the study was to describe clinical and biological characteristics and thrombotic relapses of patients diagnosed with antiphospholipid syndrome (APS) after the age of 65 years, in comparison with patients diagnosed with… read more here.
Keywords: clinical biological; patients diagnosed; antiphospholipid syndrome; thrombotic relapses ... See more keywords